In animal models of idiopathic pulmonary fibrosis, PD-1/PD-L1 blockade has been shown to be therapeutic and can reduce fibrosis that occurs due to hyperactivation of myofibroblasts induced by TGF-β [29,30]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.